KEAP1 and liver cancer: DHA can increase the inhibition of sorafenib on liver cancer [21], increase the effect of gefitinib on lung cancer by regulating the cell cycle [22], and increase the sensitivity of lung cancer and colorectal cancer to radiotherapy by activating of anti-oxidant Keap1/Nrf2 pathway [23].